Sanket Dhruva, MD, MHS
Assistant Professor
Medicine
School of Medicine

Education & Training

Show all (7) Hide

• Diversity, Equity, and Inclusion Champion Training UCSF 2021
• LEAN Champion UCSF 2019
• MHS Robert Wood Johnson Foundation Clinical Scholars Program Yale University 06/2017
• Cardiology Fellowship UC Davis Division of Cardiovascular Medicine 06/2015
• Internal Medicine Residency UCSF Department of Medicine 06/2012
• MD UCSF School of Medicine 06/2009
• BA Molecular & Cell Biology; Political Science UC Berkeley 05/2005

Interests

Show all (6) Hide

• Medical Device Regulation and Insurer Coverage
• Medical Device and Drug Safety
• High-Value Care
• Research with Digital Technologies
• Medicare Formulary Coverage
• Real-World Evidence

Publications (197)

Top publication keywords:
Drug CostsUnited States Food and Drug AdministrationIntra-Aortic Balloon PumpingDrug ApprovalMedicare Part DDefibrillators, ImplantableProduct Surveillance, PostmarketingHeart-Assist DevicesInsurance CoverageMedical Device RecallsPrescription DrugsMedicareEquipment and SuppliesDevice ApprovalFormularies as Topic

• Hospital Prices for Physician-Administered Drugs. Reply.
  The New England journal of medicine 2024 Robinson JC, Whaley C, Dhruva SS
• Intravascular Microaxial Left Ventricular Assist Device Manufacturer Payments to Cardiologists and Use of Devices.
  JAMA 2024 Dhruva SS, Ross JS, Steinman MA, Gan S, Muluk S, Anderson TS
• Prices and complications in hospital-based and freestanding surgery centers.
  The American journal of managed care 2024 Robinson JC, Whaley CM, Dhruva SS
• Informational letters or postcards to initiate remote monitoring among veterans with pacemakers and implantable cardioverter-defibrillators: A randomized, controlled trial.
  Pacing and clinical electrophysiology : PACE 2024 Kratka A, Rotering TL, Raitt MH, Whooley MA, Dhruva SS
• Monitoring of Remotely Reprogrammable Implantable Loop Recorders With Algorithms to Reduce False-Positive Alerts.
  Journal of the American Heart Association 2024 Neiman ZM, Raitt MH, Rohrbach G, Dhruva SS

Show all (192 more) Hide

• Use of Electronic Health Records to Characterize Patients with Uncontrolled Hypertension in Two Large Health System Networks.
  Research square 2024 Lu Y, Keeley EC, Barrette E, Cooper-DeHoff RM, Dhruva SS, Gaffney J, Gamble G, Handke B, Huang C, Krumholz H, Rowe C, Schulz W, Shaw K, Smith M, Woodard J, Young P, Ervin K, Ross J
• Hospital Prices for Physician-Administered Drugs for Patients with Private Insurance.
  The New England journal of medicine 2024 Robinson JC, Whaley C, Dhruva SS
• Informational Postcards Increase Engagement with Remote Monitoring Among Veterans with Pacemakers and Implantable Cardioverter-Defibrillators: a Stepped-Wedge Randomized Controlled Trial.
  Journal of general internal medicine 2024 McLaughlin MM, Raitt MH, Tarasovsky G, Whooley MA, Dhruva SS
• Physicians' Perspectives On FDA Regulation Of Drugs And Medical Devices: A National Survey.
  Health affairs (Project Hope) 2024 Dhruva SS, Kesselheim AS, Woloshin S, Ji RZ, Lu Z, Darrow JJ, Redberg RF
• Aligning US Agency Policies for Cardiovascular Devices Through the Breakthrough Devices Program.
  JAMA cardiology 2023 Moneer O, Rathi VK, Johnston JL, Ross JS, Dhruva SS
• Deep Learning of Electrocardiograms in Sinus Rhythm From US Veterans to Predict Atrial Fibrillation.
  JAMA cardiology 2023 Yuan N, Duffy G, Dhruva SS, Oesterle A, Pellegrini CN, Theurer J, Vali M, Heidenreich PA, Keyhani S, Ouyang D
• Barriers and Facilitators Associated With Remote Monitoring Adherence Among Veterans With Pacemakers and Implantable Cardioverter-Defibrillators: Qualitative Cross-Sectional Study.
  JMIR cardio 2023 Dhruva SS, Raitt MH, Munson S, Moore HJ, Steele P, Rosman L, Whooley MA
• Cardiac coronary tomography angiography (CCTA) use across geographical regions in the USA and the UK: a cross-sectional study.
  BMJ surgery, interventions, & health technologies 2023 Banashefski B, Ji R, Dhruva SS, Neuhaus J, Redberg RF
• Strategies to enhance remote monitoring adherence among patients with cardiovascular implantable electronic devices.
  Heart rhythm O2 2023 Rotering TL, Hysong SJ, Williams KE, Raitt MH, Whooley MA, Dhruva SS
• Studies Of Prescription Digital Therapeutics Often Lack Rigor And Inclusivity.
  Health affairs (Project Hope) 2023 Kumar A, Ross JS, Patel NA, Rathi V, Redberg RF, Dhruva SS
• Systematic reprogramming of implantable cardioverter-defibrillators to match the 2019 consensus recommendations.
  Heart rhythm 2023 Oesterle A, Pellegrini CN, Dhruva SS, Kizer JR, Raitt MH, Liem LB
• The Need for Randomized Clinical Trials Demonstrating Reduction in All-Cause Mortality With Blood Tests for Cancer Screening.
  JAMA internal medicine 2023 Dhruva SS, Smith-Bindman R, Redberg RF
• Unique Device Identifiers for Medical Devices at 10 Years.
  JAMA internal medicine 2023 Dhruva SS, Ross JS, Wilson NA
• Medical device risk (re)classification: lessons from the FDA's 515 Program Initiative.
  BMJ surgery, interventions, & health technologies 2023 Mooghali M, Rathi VK, Kadakia KT, Ross JS, Dhruva SS
• Financial Conflicts of Interest in Public Comments on Medicare National Coverage Determinations of Medical Devices.
  JAMA 2023 Lu A, Ji RZ, Ge AY, Ross JS, Ramachandran R, Redberg RF, Dhruva SS
• A Critical Examination of Independent Medical Review Decision-making for Cardiovascular Procedures Shows Low Rate of Evidence Citation in Reviews.
  Medical care 2023 Varadharajulu SD, Ji RZ, Dhruva SS, Neuhaus J, Redberg RF
• Clinical Phenotyping with an Outcomes-driven Mixture of Experts for Patient Matching and Risk Estimation.
  ACM transactions on computing for healthcare 2023 Hurley NC, Dhruva SS, Desai NR, Ross JR, Ngufor CG, Masoudi F, Krumholz HM, Mortazavi BJ
• Reply: The Challenge of Minimizing Unnecessary ICD Shocks While Also Preventing Syncope.
  JACC. Clinical electrophysiology 2023 Oesterle A, Liem LB, Dhruva SS, Friday G, Raitt MH, Pellegrini CN
• Payer-Negotiated Prices for Cardiac Electrophysiology Procedures at 2022-2023 Top 100 US News & World Report for Cardiology and Heart Surgery Hospitals.
  Circulation. Arrhythmia and electrophysiology 2023 Gupta K, Gupta R, Xiao R, Rathi VK, Miller PE, Ross JS, Dhruva SS
• Assessing the use of observational methods and real-world data to emulate ongoing randomized controlled trials.
  Clinical trials (London, England) 2023 Wallach JD, Deng Y, Polley EC, Dhruva SS, Herrin J, Quinto K, Gandotra C, Crown W, Noseworthy P, Yao X, Jeffery MM, Lyon TD, Ross JS, McCoy RG
• Use of Electronic Health Records to Characterize Patients with Uncontrolled Hypertension in Two Large Health System Networks.
  medRxiv : the preprint server for health sciences 2023 Lu Y, Keeley EC, Barrette E, Cooper-DeHoff RM, Dhruva SS, Gaffney J, Gamble G, Handke B, Huang C, Krumholz HM, McDonough Rowe CW, Schulz W, Shaw K, Smith M, Woodard J, Young P, Ervin K, Ross JS
• Availability of Unique Device Identifiers for Class I Medical Device Recalls From 2018 to 2022.
  JAMA internal medicine 2023 Mooghali M, Ross JS, Kadakia KT, Dhruva SS
• Physician Perspectives on the Food and Drug Administration's Decision to Grant Accelerated Approval to Aducanumab for Alzheimer's Disease.
  Clinical pharmacology and therapeutics 2023 Dhruva SS, Kesselheim AS, Woloshin S, Ji RZ, Lu Z, Darrow JJ, Redberg RF
• Characterization of US Food and Drug Administration Class I Recalls from 2018 to 2022 for Moderate- and High-Risk Medical Devices: A Cross-Sectional Study.
  Medical devices (Auckland, N.Z.) 2023 Mooghali M, Ross JS, Kadakia KT, Dhruva SS
• Challenges and solutions to advancing health equity with medical devices.
  Nature biotechnology 2023 Kadakia KT, Rathi VK, Ramachandran R, Johnston JL, Ross JS, Dhruva SS
• Physician responses to apple watch-detected irregular rhythm alerts.
  American heart journal 2023 Demkowicz PC, Dhruva SS, Spatz ES, Beatty AL, Ross JS, Khera R
• Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020.
  Journal of the American Heart Association 2023 Essa M, Ross JS, Dhruva SS, Desai NR, Yeh RW, Faridi KF
• Medical Device Modifications Through Premarket Approval Supplements-Ensuring Patient Safety.
  JAMA network open 2023 Caughron H, Dhruva SS
• Identifying treatment heterogeneity in atrial fibrillation using a novel causal machine learning method.
  American heart journal 2023 Ngufor C, Yao X, Inselman JW, Ross JS, Dhruva SS, Graham DJ, Lee JY, Siontis KC, Desai NR, Polley E, Shah ND, Noseworthy PA
• Trends in FDA Adverse Events Reporting for Inferior Vena Cava Filters and Estimated Insertions in the US, 2016 to 2020.
  JAMA internal medicine 2023 Warren RE, Dhruva SS, Kinard M, Neuhaus JM, Redberg RF
• Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018.
  BMJ surgery, interventions, & health technologies 2023 Rathi VK, Johnston JL, Dhruva S, Ross J
• Using real-world data from health systems to evaluate the safety and effectiveness of a catheter to treat ischemic ventricular tachycardia.
  Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2023 Dhruva SS, Zhang S, Chen J, Noseworthy PA, Doshi AA, Agboola KM, Herrin J, Jiang G, Yu Y, Cafri G, Farr KC, Mbwana MS, Ross JS, Coplan PM, Drozda JP
• Ventricular arrhythmia detection for contemporary Biotronik and Abbott implantable cardioverter defibrillators with markedly prolonged detection in Biotronik devices.
  Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2023 Oesterle A, Dhruva SS, Pellegrini CN, Liem B, Raitt MH
• Exploring unique device identifier implementation and use for real-world evidence: a mixed-methods study with NESTcc health system network collaborators.
  BMJ surgery, interventions, & health technologies 2023 Dhruva SS, Ridgeway JL, Ross JS, Drozda JP, Wilson NA
• Traumatic Syncope Caused by Prolonged Ventricular Arrhythmias With a Defibrillator Programmed to 2019 Consensus Recommendations.
  JACC. Clinical electrophysiology 2023 Oesterle A, Liem LB, Dhruva SS, Friday G, Raitt MH, Pellegrini CN
• Adding device identifiers to claims forms-a key step to advance medical device safety.
  BMJ (Clinical research ed.) 2023 Kadakia KT, Dhruva SS, Ross JS, Krumholz HM
• Integrating real-world data to assess cardiac ablation device outcomes in a multicenter study using the OMOP common data model for regulatory decisions: implementation and evaluation.
  JAMIA open 2023 Yu Y, Jiang G, Brandt E, Forsyth T, Dhruva SS, Zhang S, Chen J, Noseworthy PA, Doshi AA, Collison-Farr K, Kim D, Ross JS, Coplan PM, Drozda JP
• Use of Recalled Devices in New Device Authorizations Under the US Food and Drug Administration's 510(k) Pathway and Risk of Subsequent Recalls.
  JAMA 2023 Kadakia KT, Dhruva SS, Caraballo C, Ross JS, Krumholz HM
• Long-term Outcomes in Use of Opioids, Nonpharmacologic Pain Interventions, and Total Costs of Spinal Cord Stimulators Compared With Conventional Medical Therapy for Chronic Pain.
  JAMA neurology 2023 Dhruva SS, Murillo J, Ameli O, Morin PE, Spencer DL, Redberg RF, Cohen K
• Cardiovascular implantable electronic device lead safety: Harnessing real-world remote monitoring data for medical device evaluation.
  Heart rhythm 2022 Caughron H, Bowman H, Raitt MH, Whooley MA, Tarasovsky G, Shen H, Matheny ME, Selzman KA, Wang L, Major J, Odobasic H, Dhruva SS
• A Policy Approach to Reducing Low-Value Device-Based Procedure Use.
  The Milbank quarterly 2022 Dhruva SS, Bachhuber MA, Shetty A, Guidry H, Guduguntla V, Redberg RF
• Characterization of multi-domain postoperative recovery trajectories after cardiac surgery using a digital platform.
  NPJ digital medicine 2022 Mori M, Dhruva SS, Geirsson A, Krumholz HM
• Advancing the Real-World Evidence for Medical Devices through Coordinated Registry Networks.
  BMJ surgery, interventions, & health technologies 2022 Sedrakyan A, Marinac-Dabic D, Campbell B, Aryal S, Baird CE, Goodney P, Cronenwett JL, Beck AW, Paxton EW, Hu J, Brindis R, Baskin K, Cowley T, Levy J, Liebeskind DS, Poulose BK, Rardin CR, Resnic FS,…
• Medicare's National Coverage Determination for Aducanumab - A One-Off or a Pragmatic Path Forward?
  The New England journal of medicine 2022 Dhruva SS, Ramachandran R, Ross JS
• Quantification of Device-Related Event Reports Associated With the CardioMEMS Heart Failure System.
  Circulation. Cardiovascular quality and outcomes 2022 Lin AL, Hu G, Dhruva SS, Kinard M, Redberg RF
• Analysis of Patient-Focused Information About Left Atrial Appendage Occlusion on US Hospital Web Pages.
  JAMA internal medicine 2022 Dhruva SS, Ji RZ, Ross JS, Spatz ES, Redberg RF
• Emulating the GRADE trial using real world data: retrospective comparative effectiveness study.
  BMJ (Clinical research ed.) 2022 Deng Y, Polley EC, Wallach JD, Dhruva SS, Herrin J, Quinto K, Gandotra C, Crown W, Noseworthy P, Yao X, Lyon TD, Shah ND, Ross JS, McCoy RG
• Gender Differences in Guideline-Directed Medical Therapy for Cardiovascular Disease Among Young Veterans.
  Journal of general internal medicine 2022 Dhruva SS, Dziura J, Bathulapalli H, Rosman L, Gaffey AE, Davis MB, Brandt CA, Haskell SG
• Safety and Effectiveness of a Catheter With Contact Force and 6-Hole Irrigation for Ablation of Persistent Atrial Fibrillation in Routine Clinical Practice.
  JAMA network open 2022 Dhruva SS, Zhang S, Chen J, Noseworthy PA, Doshi AA, Agboola KM, Herrin J, Jiang G, Yu Y, Cafri G, Collison Farr K, Ervin KR, Ross JS, Coplan PM, Drozda JP
• Diffusion of Percutaneous Ventricular Assist Devices in US Markets.
  Circulation. Cardiovascular interventions 2022 Bjarnason TA, Mentias A, Panaich S, Vaughan Sarrazin M, Gao Y, Desai M, Pandey A, Dhruva SS, Desai NR, Girotra S
• Implantable cardioverter-defibrillator placement among patients with left ventricular ejection fraction ≤35 % at least 40 days after acute myocardial infarction.
  American heart journal plus : cardiology research and practice 2022 Judson GL, Cohen BE, Muniyappa A, Raitt MH, Shen H, Tarasovsky G, Whooley MA, Dhruva SS
• Medicare Coverage and Out-of-Pocket Costs of Quadruple Drug Therapy for Heart Failure.
  Journal of the American College of Cardiology 2022 Faridi KF, Dayoub EJ, Ross JS, Dhruva SS, Ahmad T, Desai NR
• Medical Device User Fee Reauthorization - Back to Basics or Looking Ahead?
  The New England journal of medicine 2022 Rathi VK, Ross JS, Redberg RF, Dhruva SS
• US Food and Drug Administration-Mandated Postmarketing Studies for High-risk Cardiovascular Devices Approved 2015-2019.
  JAMA internal medicine 2022 Hidano D, Dhruva SS, Redberg RF
• Factors associated with remote monitoring adherence for cardiovascular implantable electronic devices.
  Heart rhythm 2022 Muniyappa AN, Raitt MH, Judson GL, Shen H, Tarasovsky G, Whooley MA, Dhruva SS
• Letter by Dhruva and Redberg Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
  Circulation 2022 Dhruva SS, Redberg RF
• Strategies to Manage Drugs and Devices Approved Based on Limited Evidence: Results of a Modified Delphi Panel.
  Clinical pharmacology and therapeutics 2022 Dhruva SS, Darrow JJ, Kesselheim AS, Redberg RF
• Evaluation of cardiovascular implantable electronic device leads post implant: ElectroPhysiology Predictable And SuStainable Implementation Of National Registries (EP PASSION).
  Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2022 Dhruva SS, Zeitler EP, Caños D, Odobasic H, Major JM, Wang L, Mullane S, Nabutovsky Y, Smith V, Zhang L, Selzman KA
• Experts' Views on FDA Regulatory Standards for Drug and High-Risk Medical Devices: Implications for Patient Care.
  Journal of general internal medicine 2022 Dhruva SS, Darrow JJ, Kesselheim AS, Redberg RF
• 2021 Update on Pediatric Overuse.
  Pediatrics 2022 Money NM, Schroeder AR, Quinonez RA, Ho T, Marin JR, Wolf ER, Morgan DJ, Dhruva SS, Coon ER
• Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019.
  JAMA internal medicine 2022 Zhou T, Liu P, Dhruva SS, Shah ND, Ramachandran R, Berg KM, Ross JS
• A 510(k) ancestry of robotic surgical systems.
  International journal of surgery (London, England) 2022 Liebeskind AY, Chen AC, Dhruva SS, Sedrakyan A
• Heart Watch Study: protocol for a pragmatic randomised controlled trial.
  BMJ open 2021 Dhruva SS, Shah ND, Vemulapalli S, Deshmukh A, Beatty AL, Gamble GM, Freeman JV, Hummel JP, Piccini JP, Akar JG, Ervin K, Arges KL, Emanuel L, Noseworthy PA, Hu T, Bartlett V, Ross JS
• Feasibility of using real-world data in the evaluation of cardiac ablation catheters: a test-case of the National Evaluation System for Health Technology Coordinating Center.
  BMJ surgery, interventions, & health technologies 2021 Dhruva SS, Jiang G, Doshi AA, Friedman DJ, Brandt E, Chen J, Akar JG, Ross JS, Ervin KR, Collison Farr K, Shah ND, Coplan P, Noseworthy PA, Zhang S, Forsyth T, Schulz WL, Yu Y, Drozda JP
• Coverage of Transvenous Pulmonary Embolectomy - Medicare's Missed Opportunity for Evidence Generation.
  The New England journal of medicine 2021 Dhruva SS, Redberg RF
• Resource Utilization Following Coronary Computed Tomographic Angiography and Stress Echocardiography in Patients Presenting to the Emergency Department With Chest Pain.
  The American journal of cardiology 2021 Sturts A, Ruzieh M, Dhruva SS, Peterson B, Mandrola JM, Liu G, Redberg RF, Foy AJ
• Characteristics, interventions and outcomes of patients with valvular heart disease hospitalised in China: a cross-sectional study.
  BMJ open 2021 Huang X, Dhruva SS, Yuan X, Bai X, Lu Y, Yan X, Liu J, Li W, Hu D, Ji R, Gao M, Miao F, Li J, Ge J, Krumholz HM, Li J
• Feasibility of Using Real-world Data to Emulate Postapproval Confirmatory Clinical Trials of Therapeutic Agents Granted US Food and Drug Administration Accelerated Approval.
  JAMA network open 2021 Wallach JD, Zhang AD, Skydel JJ, Bartlett VL, Dhruva SS, Shah ND, Ross JS
• Clinical studies sponsored by digital health companies participating in the FDA's Precertification Pilot Program: A cross-sectional analysis.
  Clinical trials (London, England) 2021 Bartlett VL, Dhruva SS, Shah ND, Ross JS
• Assessment of FDA Approval for New High-risk Therapeutic Devices Not Meeting Pivotal Study Primary End Points, 2016-2020.
  JAMA internal medicine 2021 Johnston JL, Dhruva SS, Ross JS, Rathi VK
• Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment.
  JAMA network open 2021 Wallach JD, Deng Y, McCoy RG, Dhruva SS, Herrin J, Berkowitz A, Polley EC, Quinto K, Gandotra C, Crown W, Noseworthy P, Yao X, Shah ND, Ross JS, Lyon TD
• Reply to the Editor-Denominator neglect in meta-analysis: electrical abnormalities in St. Jude/Abbott pacing leads.
  Heart rhythm 2021 Oesterle A, Dhruva SS
• Feasibility of capturing real-world data from health information technology systems at multiple centers to assess cardiac ablation device outcomes: A fit-for-purpose informatics analysis report.
  Journal of the American Medical Informatics Association : JAMIA 2021 Jiang G, Dhruva SS, Chen J, Schulz WL, Doshi AA, Noseworthy PA, Zhang S, Yu Y, Patrick Young H, Brandt E, Ervin KR, Shah ND, Ross JS, Coplan P, Drozda JP
• Reporting of Death in US Food and Drug Administration Medical Device Adverse Event Reports in Categories Other Than Death.
  JAMA internal medicine 2021 Lalani C, Kunwar EM, Kinard M, Dhruva SS, Redberg RF
• Electrical abnormalities with St. Jude/Abbott pacing leads: A systematic review and meta-analysis.
  Heart rhythm 2021 Khatiwala RV, Mullins E, Fan D, Srivatsa UN, Dhruva SS, Oesterle A
• Trajectories of Pain After Cardiac Surgery: Implications for Measurement, Reporting, and Individualized Treatment.
  Circulation. Cardiovascular quality and outcomes 2021 Mori M, Brooks C, Dhruva SS, Lu Y, Spatz ES, Dey P, Zhang Y, Chaudhry SI, Geirsson A, Allore HG, Krumholz HM
• Physical activity, patient-reported symptoms, and clinical events: Insights into postprocedural recovery from personal digital devices.
  Cardiovascular digital health journal 2021 Bartlett VL, Ross JS, Shah ND, Ciaccio L, Akar JG, Noseworthy PA, Dhruva SS
• US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018.
  Clinical trials (London, England) 2021 Skydel JJ, Zhang AD, Dhruva SS, Ross JS, Wallach JD
• Changing FDA Approval Standards: Ethical Implications for Patient Consent.
  Journal of general internal medicine 2021 Darrow JJ, Dhruva SS, Redberg RF
• Medicare's New Device-Coverage Pathway - Breakthrough or Breakdown?
  The New England journal of medicine 2021 Rathi VK, Johnston JL, Ross JS, Dhruva SS
• Media Portrayals of Extracorporeal Membrane Oxygenation: The Unforeseen Harm of Unfounded Optimism.
  JAMA internal medicine 2021 Holtzman JN, Dhruva SS
• GLASS(Y) Half-Full: Moving Towards Greater Pragmatism in Outcome Ascertainment for Clinical Trials.
  Circulation. Cardiovascular quality and outcomes 2021 Dhruva SS
• Characteristics and Reporting of Number Needed to Treat, Number Needed to Harm, and Absolute Risk Reduction in Controlled Clinical Trials, 2001-2019.
  JAMA internal medicine 2021 Elliott MH, Skydel JJ, Dhruva SS, Ross JS, Wallach JD
• Use of Mechanical Circulatory Support Devices Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.
  JAMA network open 2021 Dhruva SS, Ross JS, Mortazavi BJ, Hurley NC, Krumholz HM, Curtis JP, Berkowitz AP, Masoudi FA, Messenger JC, Parzynski CS, Ngufor CG, Girotra S, Amin AP, Shah ND, Desai NR
• Trends in Within-Class Changes in US Average Wholesale Prices for Brand-Name Medications for Common Conditions From 2015 to 2020.
  JAMA network open 2021 Liu P, Dhruva SS, Shah ND, Ross JS
• Catheter-related complications and mortality of atrial fibrillation ablation following introduction of contact force-sensing technology.
  BMJ surgery, interventions, & health technologies 2020 Akar JG, Hummel JP, Yao X, Sangaralingham L, Dhruva S, Dong J, Ward R, Shah ND, Ross J, Noseworthy PA
• Clinical Evidence Supporting US Food and Drug Administration Clearance of Novel Therapeutic Devices via the De Novo Pathway Between 2011 and 2019.
  JAMA internal medicine 2020 Johnston JL, Dhruva SS, Ross JS, Rathi VK
• Mandatory Registration and Results Reporting of Real-World Evidence Studies of FDA-Regulated Medical Products.
  Mayo Clinic proceedings 2020 Dhruva SS, Shah ND, Ross JS
• Protocol for project recovery after cardiac surgery: a single-center cohort study leveraging digital platform to characterise longitudinal patient-reported postoperative recovery patterns.
  BMJ open 2020 Mori M, Brooks C, Spatz E, Mortazavi BJ, Dhruva SS, Linderman GC, Grab LA, Zhang Y, Geirsson A, Chaudhry SI, Krumholz HM
• Early experience with the FDA's Breakthrough Devices program.
  Nature biotechnology 2020 Johnston JL, Dhruva SS, Ross JS, Rathi VK
• Endoscopic transmission of carbapenem-resistant Enterobacteriaceae: implications for U.S. Food and Drug Administration approval and postmarket surveillance of endoscopic devices.
  Gastrointestinal endoscopy 2020 Saleem N, Ismail MK, Tombazzi CR, Soin S, Dhruva SS
• Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump for Cardiogenic Shock-Reply.
  JAMA 2020 Dhruva SS, Mortazavi BJ, Desai NR
• Aggregating multiple real-world data sources using a patient-centered health-data-sharing platform.
  NPJ digital medicine 2020 Dhruva SS, Ross JS, Akar JG, Caldwell B, Childers K, Chow W, Ciaccio L, Coplan P, Dong J, Dykhoff HJ, Johnston S, Kellogg T, Long C, Noseworthy PA, Roberts K, Saha A, Yoo A, Shah ND
• The Art of the Deal: Negotiating Consult Conflict.
  The American journal of medicine 2020 Wray CM, Dhruva SS, Dhaliwal G
• Active Surveillance of the Implantable Cardioverter-Defibrillator Registry for Defibrillator Lead Failures.
  Circulation. Cardiovascular quality and outcomes 2020 Resnic FS, Majithia A, Dhruva SS, Ssemaganda H, Robbins S, Marinac-Dabic D, Hewitt K, Ohno-Machado L, Reynolds MR, Matheny ME
• Commentary on Bertagnolli et al.: Leveraging electronic health record data for clinical trials-a brave new world.
  Clinical trials (London, England) 2020 Ross JS, Dhruva SS, Shah ND
• 2019 Update on Pediatric Medical Overuse: A Systematic Review.
  JAMA pediatrics 2020 Money NM, Schroeder AR, Quinonez RA, Ho T, Marin JR, Morgan DJ, Dhruva SS, Coon ER
• A Successful but Underused Strategy for Reducing Low-Value Care: Stop Paying for It.
  JAMA internal medicine 2020 Dhruva SS, Redberg RF
• Medicare Prescription Drug Plan Coverage of Hormone Therapies Used by Transgender Individuals.
  LGBT health 2020 Solotke MT, Liu P, Dhruva SS, Gulanski B, Shah ND, Ross JS
• Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017.
  Journal of managed care & specialty pharmacy 2020 Bartlett VL, Liu P, Dhruva SS, Shah ND, Bollinger KE, Ross JS
• Medicare beneficiaries' out-of-pocket costs for commonly used generic drugs, 2009-2017.
  The American journal of managed care 2020 Liu P, Dhruva SS, Shah ND, Ross JS
• Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.
  JAMA 2020 Dhruva SS, Ross JS, Mortazavi BJ, Hurley NC, Krumholz HM, Curtis JP, Berkowitz A, Masoudi FA, Messenger JC, Parzynski CS, Ngufor C, Girotra S, Amin AP, Shah ND, Desai NR
• Attribution of Adverse Events Following Coronary Stent Placement Identified Using Administrative Claims Data.
  Journal of the American Heart Association 2020 Dhruva SS, Parzynski CS, Gamble GM, Curtis JP, Desai NR, Yeh RW, Masoudi FA, Kuntz R, Shaw RE, Marinac-Dabic D, Sedrakyan A, Normand ST, Krumholz HM, Ross JS
• Physician and Patient Adjustment to Reference Pricing for Drugs.
  JAMA network open 2020 Robinson JC, Whaley C, Brown TT, Dhruva SS
• Prevalence and significance of race and ethnicity subgroup analyses in Cochrane intervention reviews.
  Clinical trials (London, England) 2019 Liu P, Ross JS, Ioannidis JP, Dhruva SS, Vasiliou V, Wallach JD
• 2019 Update on Medical Overuse: A Review.
  JAMA internal medicine 2019 Morgan DJ, Dhruva SS, Coon ER, Wright SM, Korenstein D
• Medicare Prescription Drug Plan Formulary Restrictions After Postmarket FDA Black Box Warnings.
  Journal of managed care & specialty pharmacy 2019 Solotke MT, Ross JS, Shah ND, Karaca-Mandic P, Dhruva SS
• Medicare Spending on Drugs and Biologics Not Recommended for Coverage by International Health Technology Assessment Agencies.
  Journal of general internal medicine 2019 Egilman AC, Wallach JD, Dhruva SS, Gonsalves GS, Ross JS
• Age-treatment subgroup analyses in Cochrane intervention reviews: a meta-epidemiological study.
  BMC medicine 2019 Liu P, Ioannidis JPA, Ross JS, Dhruva SS, Luxkaranayagam AT, Vasiliou V, Wallach JD
• Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics.
  Journal of general internal medicine 2019 Vijay A, Gupta R, Liu P, Dhruva SS, Shah ND, Ross JS
• Feasibility of Using Real-World Data to Replicate Clinical Trial Evidence.
  JAMA network open 2019 Bartlett VL, Dhruva SS, Shah ND, Ryan P, Ross JS
• Use of Mechanical Cardiopulmonary Resuscitation Devices for Out-of-Hospital Cardiac Arrest, 2010-2016.
  JAMA network open 2019 Kahn PA, Dhruva SS, Rhee TG, Ross JS
• Evolution of Medicare Formulary Coverage Changes for Antithrombotic Therapies After Guideline Updates.
  Circulation 2019 Dayoub EJ, Ross JS, Shah ND, Dhruva SS
• Evolution of the American College of Cardiology and American Heart Association Cardiology Clinical Practice Guidelines: A 10-Year Assessment.
  Journal of the American Heart Association 2019 DuBose-Briski V, Yao X, Dunlay SM, Dhruva SS, Ross JS, Shah ND, Noseworthy PA
• Moving From Substantial Equivalence to Substantial Improvement for 510(k) Devices.
  JAMA 2019 Redberg RF, Dhruva SS
• Disparities in Socioeconomic Context and Association With Blood Pressure Control and Cardiovascular Outcomes in ALLHAT.
  Journal of the American Heart Association 2019 Shahu A, Herrin J, Dhruva SS, Desai NR, Davis BR, Krumholz HM, Spatz ES
• Controversies in Diagnostic Imaging of Patients With Suspected Stable and Acute Chest Pain Syndromes.
  JACC. Cardiovascular imaging 2019 Shaw LJ, Blankstein R, Brown DL, Dhruva SS, Douglas PS, Genders TSS, Gibbons RJ, Greenwood JP, Kwong R, Leipsic J, Mahmarian JJ, Maron D, Nagel E, Nicol E, Nieman K, Pellikka PA, Redberg RF, Weir-…
• Evaluation of technologies approved for supplemental payments in the United States.
  BMJ (Clinical research ed.) 2019 Judson TJ, Dhruva SS, Redberg RF
• Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis.
  BMC medicine 2019 Wallach JD, Luxkaranayagam AT, Dhruva SS, Miller JE, Ross JS
• Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or Commitments.
  JAMA network open 2019 Skydel JJ, Luxkaranayagam AT, Dhruva SS, Ross JS, Wallach JD
• Clinical Interpretation of High-Sensitivity Troponin Testing-Reply.
  JAMA internal medicine 2019 Morgan DJ, Dhruva SS, Korenstein D
• 2018 Update on Pediatric Medical Overuse: A Review.
  JAMA pediatrics 2019 Coon ER, Quinonez RA, Morgan DJ, Dhruva SS, Ho T, Money N, Schroeder AR
• Medicare Formulary Coverage and Restrictions for Opioid Potentiators from 2013 to 2017.
  Journal of general internal medicine 2019 Vijay A, Ross JS, Shah ND, Jeffery MM, Dhruva SS
• 2018 Update on Medical Overuse.
  JAMA internal medicine 2019 Morgan DJ, Dhruva SS, Coon ER, Wright SM, Korenstein D
• Implementation of an EConsult System with Patient Navigation.
  Journal of health care for the poor and underserved 2019 Dhruva SS
• Coverage of Novel Therapeutic Agents by Medicare Prescription Drug Plans Following FDA Approval.
  Journal of managed care & specialty pharmacy 2018 Shaw DL, Dhruva SS, Ross JS
• Enhancing the prediction of acute kidney injury risk after percutaneous coronary intervention using machine learning techniques: A retrospective cohort study.
  PLoS medicine 2018 Huang C, Murugiah K, Mahajan S, Li SX, Dhruva SS, Haimovich JS, Wang Y, Schulz WL, Testani JM, Wilson FP, Mena CI, Masoudi FA, Rumsfeld JS, Spertus JA, Mortazavi BJ, Krumholz HM
• Alirocumab's Price Reduction.
  Circulation 2018 Dhruva SS, Ross JS, Desai NR
• Assessment of Clinical Trial Evidence for High-Risk Cardiovascular Devices Approved Under the Food and Drug Administration Priority Review Program.
  JAMA internal medicine 2018 Jones LC, Dhruva SS, Redberg RF
• Evidence supporting FDA approval and CMS national coverage determinations for novel medical products, 2005 through 2016: A cross-sectional study.
  Medicine 2018 Roginiel AC, Dhruva SS, Ross JS
• Trends in Use of Transcatheter Aortic Valve Replacement by Age.
  JAMA 2018 Sedrakyan A, Dhruva SS, Sun T, Mao J, Gaudino MFL, Redberg RF
• Age of Data at the Time of Publication of Contemporary Clinical Trials.
  JAMA network open 2018 Welsh J, Lu Y, Dhruva SS, Bikdeli B, Desai NR, Benchetrit L, Zimmerman CO, Mu L, Ross JS, Krumholz HM
• Real-World Evidence: Promise and Peril For Medical Product Evaluation.
  P & T : a peer-reviewed journal for formulary management 2018 Dhruva SS, Ross JS, Desai NR
• Medicare Beneficiary Out-of-Pocket Costs for Generic Cardiovascular Medications Available Through $4 Generic Drug Discount Programs.
  Annals of internal medicine 2018 Liu P, Dhruva SS, Shah ND, Ross JS
• Accurate estimation of cardiovascular risk in a non-diabetic adult: detecting and correcting the error in the reported Framingham Risk Score for the Systolic Blood Pressure Intervention Trial population.
  BMJ open 2018 Warner F, Dhruva SS, Ross JS, Dey P, Murugiah K, Krumholz HM
• Continuing to Improve Appropriateness of Continuous Electrocardiographic Monitoring (Telemetry).
  JAMA internal medicine 2018 Dhruva SS
• Quantifying the utilization of medical devices necessary to detect postmarket safety differences: A case study of implantable cardioverter defibrillators.
  Pharmacoepidemiology and drug safety 2018 Bates J, Parzynski CS, Dhruva SS, Coppi A, Kuntz R, Li SX, Marinac-Dabic D, Masoudi FA, Shaw RE, Warner F, Krumholz HM, Ross JS
• Fulfilling the Promise of Unique Device Identifiers.
  Annals of internal medicine 2018 Dhruva SS, Ross JS, Schulz WL, Krumholz HM
• Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis.
  BMJ (Clinical research ed.) 2018 Wallach JD, Egilman AC, Dhruva SS, McCarthy ME, Miller JE, Woloshin S, Schwartz LM, Ross JS
• 2017 Update on Pediatric Medical Overuse: A Review.
  JAMA pediatrics 2018 Coon ER, Young PC, Quinonez RA, Morgan DJ, Dhruva SS, Schroeder AR
• Medicare Spending and Potential Savings on Brand-Name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015.
  JAMA internal medicine 2018 Egilman AC, Wallach JD, Ross JS, Dhruva SS
• Medical Overuse of Prostate-Specific Antigen Testing and Overprescription of Antibiotics-Reply.
  JAMA internal medicine 2018 Morgan DJ, Dhruva SS, Korenstein D
• 2017 Update on Medical Overuse: A Systematic Review.
  JAMA internal medicine 2018 Morgan DJ, Dhruva SS, Coon ER, Wright SM, Korenstein D
• New and incremental FDA black box warnings from 2008 to 2015.
  Expert opinion on drug safety 2017 Solotke MT, Dhruva SS, Downing NS, Shah ND, Ross JS
• Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results.
  Journal of the American Heart Association 2017 Huang C, Dhruva SS, Coppi AC, Warner F, Li SX, Lin H, Nasir K, Krumholz HM
• Coronary Computed Tomography Angiography vs Functional Stress Testing for Patients With Suspected Coronary Artery Disease: A Systematic Review and Meta-analysis.
  JAMA internal medicine 2017 Foy AJ, Dhruva SS, Peterson B, Mandrola JM, Morgan DJ, Redberg RF
• Requiem for a Scaffold.
  Annals of internal medicine 2017 Dhruva SS, Curtis JP
• Medicare Formulary Coverage Restrictions for Prescription Opioids, 2006 to 2015.
  Annals of internal medicine 2017 Samuels EA, Ross JS, Dhruva SS
• Merits of Data Sharing: The Digitalis Investigation Group Trial.
  Journal of the American College of Cardiology 2017 Angraal S, Ross JS, Dhruva SS, Desai NR, Welsh JW, Krumholz HM
• The FDA Unapproved Drugs Initiative: An Observational Study of the Consequences for Drug Prices and Shortages in the United States.
  Journal of managed care & specialty pharmacy 2017 Gupta R, Dhruva SS, Fox ER, Ross JS
• Association between FDA black box warnings and Medicare formulary coverage changes.
  The American journal of managed care 2017 Dhruva SS, Karaca-Mandic P, Shah ND, Shaw DL, Ross JS
• Author's Response.
  Pediatrics 2017 Coon ER, Young PC, Quinonez RA, Morgan DJ, Dhruva SS, Schroeder AR
• Inclusion of Demographic-Specific Information in Studies Supporting US Food & Drug Administration Approval of High-Risk Medical Devices.
  JAMA internal medicine 2017 Dhruva SS, Mazure CM, Ross JS, Redberg RF
• Characteristics of Clinical Studies Used for US Food and Drug Administration Approval of High-Risk Medical Device Supplements.
  JAMA 2017 Zheng SY, Dhruva SS, Redberg RF
• Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
  Hypertension (Dallas, Tex. : 1979) 2017 Dhruva SS, Huang C, Spatz ES, Coppi AC, Warner F, Li SX, Lin H, Xu X, Furberg CD, Davis BR, Pressel SL, Coifman RR, Krumholz HM
• FDA Drug Trials Snapshots-A Clearer Picture.
  JAMA internal medicine 2017 Dhruva SS, Redberg RF
• Real-World Data on Heart Failure Readmission Reduction: Real or Real Uncertain?
  Journal of the American College of Cardiology 2017 Krumholz HM, Dhruva SS
• Transcatheter Aortic Valve Replacement in Younger Individuals.
  JAMA internal medicine 2017 Sedrakyan A, Dhruva SS, Shuhaiber J
• Letter by Dhruva and Redberg Regarding Article, "Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Program".
  Circulation 2017 Dhruva SS, Redberg RF
• Medicare Formulary Changes After the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline.
  Journal of the American College of Cardiology 2017 Dhruva SS, Desai NR, Karaca-Mandic P, Shah ND, Ross JS
• Update on Pediatric Overuse.
  Pediatrics 2017 Coon ER, Young PC, Quinonez RA, Morgan DJ, Dhruva SS, Schroeder AR
• 2016 Update on Medical Overuse: A Systematic Review.
  JAMA internal medicine 2016 Morgan DJ, Dhruva SS, Wright SM, Korenstein D
• For the Patient with "Low-risk Chest Pain"-How Low Is Low?
  Academic radiology 2016 Foy AJ, Dhruva SS, Mandrola J
• Sex-Specific Data for the Subcutaneous Implantable Cardioverter-Defibrillator.
  Journal of the American College of Cardiology 2016 Dhruva SS, Redberg RF
• Championing Effectiveness Before Cost-Effectiveness.
  JACC. Heart failure 2016 Dhruva SS, Krumholz HM
• Application of Medicare's New Technology Add-on Payment Program for Blinatumomab.
  JAMA oncology 2016 Dhruva SS, Prasad V
• The Core Value of Cost-Effectiveness Analyses.
  Journal of the American College of Cardiology 2016 Dhruva SS, Krumholz HM
• Update on Medical Practices That Should Be Questioned in 2015.
  JAMA internal medicine 2015 Morgan DJ, Dhruva SS, Wright SM, Korenstein D
• Revisiting Essure--Toward Safe and Effective Sterilization.
  The New England journal of medicine 2015 Dhruva SS, Ross JS, Gariepy AM
• Setting a research agenda for medical overuse.
  BMJ (Clinical research ed.) 2015 Morgan DJ, Brownlee S, Leppin AL, Kressin N, Dhruva SS, Levin L, Landon BE, Zezza MA, Schmidt H, Saini V, Elshaug AG
• Here Today, Gone Tomorrow.
  The American journal of medicine 2015 Sab S, Dhruva SS, Paulsen J, Sidhu RS, Amsterdam EA, Venugopal S
• Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports.
  BMJ (Clinical research ed.) 2015 Chang L, Dhruva SS, Chu J, Bero LA, Redberg RF
• Evidence And Medicare's Coverage Of Interventions.
  Health affairs (Project Hope) 2015 Dhruva SS, Redberg RF
• Update on medical overuse.
  JAMA internal medicine 2015 Morgan DJ, Wright SM, Dhruva S
• Presumed safe no more: lessons from the Wingspan saga on regulation of devices.
  BMJ (Clinical research ed.) 2014 Gartenberg AJ, Peleg A, Dhruva SS, Redberg RF
• A double-edged sword.
  Journal of hospital medicine 2013 Baxi S, Platts-Mills J, Dhruva S, Huang L, Hanks D, Dhaliwal G
• FDA regulation of cardiovascular devices and opportunities for improvement.
  Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2012 Dhruva SS, Redberg RF
• Inclusion of comparative effectiveness data in high-risk cardiovascular device studies at the time of premarket approval.
  JAMA 2012 Chen CE, Dhruva SS, Redberg RF
• Medical device regulation: time to improve performance.
  PLoS medicine 2012 Dhruva SS, Redberg RF
• Evaluating sex differences in medical device clinical trials: time for action.
  JAMA 2012 Dhruva SS, Redberg RF
• Withdrawing unsafe drugs from the market.
  Health affairs (Project Hope) 2011 Dhruva SS, Redberg RF
• Sex-specific outcomes for HeartMate II.
  Journal of the American College of Cardiology 2011 Dhruva SS, Redberg RF
• Transcatheter aortic-valve replacement.
  The New England journal of medicine 2011 Redberg RF, Dhruva SS
• Clinical trial enrollment and progress in women's health.
  JAMA 2011 Dhruva SS, Redberg RF
• Gender bias in studies for Food and Drug Administration premarket approval of cardiovascular devices.
  Circulation. Cardiovascular quality and outcomes 2011 Dhruva SS, Bero LA, Redberg RF
• Medical device recalls: get it right the first time: Comment on "Medical device recalls and the FDA approval process".
  Archives of internal medicine 2011 Redberg RF, Dhruva SS
• Inclusion of training patients in US Food and Drug Administration premarket approval cardiovascular device studies.
  Archives of internal medicine 2010 Chen CE, Dhruva SS, Bero LA, Redberg RF
• Accelerated approval and possible withdrawal of midodrine.
  JAMA 2010 Dhruva SS, Redberg RF
• The need for sex-specific data prior to food and drug administration approval.
  Journal of the American College of Cardiology 2010 Dhruva SS, Redberg RF
• Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices.
  JAMA 2009 Dhruva SS, Bero LA, Redberg RF
• CMS's landmark decision on CT colonography--examining the relevant data.
  The New England journal of medicine 2009 Dhruva SS, Phurrough SE, Salive ME, Redberg RF
• Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions.
  Archives of internal medicine 2008 Dhruva SS, Redberg RF